← All organizations

Highest phase reached

Phase 3

First clinical trial

Jan 10, 2003

Last known activity

Jan 12, 2010

Acquired by Intrexon on Jan 24, 2017

Timeline

1990s

  1. Jun 1, 1992

    GenVec— Founded

2010s

  1. Jan 24, 2017

    Intrexon— Acquired By

Drugs by trial phase (3 distinct, 9 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Recent trials (9)

Details

Founded
Gaithersburg, MD, US Jun 1, 1992
Last known activity
Jan 12, 2010